Once-a-day tablet for bladder cancer given the green light by NICE

Jeff Moore/PA Wire

By Storm Newton, PA Media

The first targeted treatment for the most common form of bladder cancer has been given the green light.

Erdafitinib, taken as a once-a-day tablet at home, has been recommended by NICE.